Gingko Dipertene Lactone Meglumine Improves Functional Outcome in Stroke Patients
Written by Chrystal Moulton, Science Writer. 50.8% of patients in the treatment group and 44.1% of patients in the placebo group achieved mRS score of 0 or 1 at 90 days (p<0.001).





